| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1101082244 |
| P356 | DOI | 10.1186/S12985-018-0942-6 |
| P932 | PMC publication ID | 5816532 |
| P698 | PubMed publication ID | 29454382 |
| P2093 | author name string | Adele Schwartz Benzaken | |
| Meritxell Sabidó | |||
| Kátia Luz Torres | |||
| Cynthia de Oliveira Ferreira | |||
| André Luiz Leturiondo | |||
| Monique Figueiredo Teixeira | |||
| P2860 | cites work | Global cancer statistics | Q22241238 |
| Condom use and the risk of genital human papillomavirus infection in young women | Q28247581 | ||
| Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia | Q28296557 | ||
| Epidemiological data of different human papillomavirus genotypes in cervical specimens of HIV-1-infected women without history of cervical pathology | Q33398500 | ||
| Human papillomavirus-related disease in people with HIV | Q33425662 | ||
| Carcinogenicity of Human Papillomavirus (HPV) Types in HIV-Positive Women: A Meta-Analysis From HPV Infection to Cervical Cancer | Q33589259 | ||
| Influence of adherent and effective antiretroviral therapy use on human papillomavirus infection and squamous intraepithelial lesions in human immunodeficiency virus-positive women | Q33638545 | ||
| Cervical HPV infection in Brazil: systematic review. | Q33705353 | ||
| Risk factors for cervical precancer and cancer in HIV-infected, HPV-positive Rwandan women | Q33728067 | ||
| Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students | Q33963919 | ||
| The 2001 Bethesda System: terminology for reporting results of cervical cytology | Q34124761 | ||
| Cervical dysplasia in women infected with the human immunodeficiency virus (HIV): a correlation with HIV viral load and CD4+ count. | Q34192533 | ||
| High prevalence of human papillomavirus (HPV) infections and high frequency of multiple HPV genotypes in human immunodeficiency virus-infected women in Brazil | Q34197471 | ||
| Human papillomavirus infection in HIV-1 infected women in Catalonia (Spain): implications for prevention of cervical cancer. | Q34464591 | ||
| A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica | Q34557325 | ||
| A cross sectional study of HPV type prevalence according to age and cytology | Q34567575 | ||
| Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis | Q34642665 | ||
| Association of human papillomavirus with HIV and CD4 cell count in women with high or low numbers of sex partners | Q35562573 | ||
| Potential impact of a nonavalent HPV vaccine on the occurrence of HPV-related diseases in France | Q35610248 | ||
| A cross-sectional study of high-risk human papillomavirus clustering and cervical outcomes in HIV-infected women in Rio de Janeiro, Brazil | Q35671337 | ||
| HPV Infection and Cervical Screening in Socially Isolated Indigenous Women Inhabitants of the Amazonian Rainforest. | Q35711091 | ||
| Comparison of Onclarity Human Papillomavirus (HPV) Assay with Hybrid Capture II HPV DNA Assay for Detection of Cervical Intraepithelial Neoplasia Grade 2 and 3 Lesions | Q35757654 | ||
| Risk of high-grade squamous intraepithelial lesion in HIV-infected adolescents | Q35892316 | ||
| Human papillomavirus and invasive cervical cancer in Brazil | Q35978093 | ||
| Clinical and Analytical Performance of the Onclarity HPV Assay Using the VALGENT Framework | Q36066822 | ||
| Associations of Human Papillomavirus (HPV) genotypes with high-grade cervical neoplasia (CIN2+) in a cohort of women living with HIV in Burkina Faso and South Africa | Q36319807 | ||
| Age-dependent prevalence of 14 high-risk HPV types in the Netherlands: implications for prophylactic vaccination and screening | Q36459799 | ||
| Biology of HPV in HIV infection | Q36467682 | ||
| Risk of cervical precancer and cancer among HIV-infected women with normal cervical cytology and no evidence of oncogenic HPV infection | Q36567658 | ||
| Human papillomavirus genotype distribution and cervical squamous intraepithelial lesions among high-risk women with and without HIV-1 infection in Burkina Faso | Q36612102 | ||
| Prevalence and determinants of HPV infection among Colombian women with normal cytology | Q36623952 | ||
| High prevalence and genotypic diversity of the human papillomavirus in Amazonian women, Brazil | Q37127255 | ||
| Does pretreatment HPV viral load correlate with prognosis in patients with early stage cervical carcinoma? | Q37177607 | ||
| The BD Onclarity HPV Assay on Samples Collected in SurePath Medium Meets the International Guidelines for Human Papillomavirus Test Requirements for Cervical Screening | Q37218627 | ||
| Age-specific prevalence of infection with human papillomavirus in females: a global review | Q37276309 | ||
| Efficacy, duration of immunity and cross protection after HPV vaccination: a review of the evidence | Q37500742 | ||
| Comparison of three human papillomavirus DNA detection methods: Next generation sequencing, multiplex-PCR and nested-PCR followed by Sanger based sequencing. | Q38959502 | ||
| High-risk human papillomavirus and cervical lesions among women living with HIV/AIDS in Brazilian Amazon, Brazil. | Q39463272 | ||
| Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings | Q39818684 | ||
| Prevalence of human papillomavirus genotypes and related abnormalities of cervical cytological results among HIV-1-infected women in Rochester, New York | Q40306611 | ||
| Human Papillomavirus infection and cervical lesions in HIV infected women on antiretroviral treatment in Thailand | Q40310711 | ||
| Immunodeficiency and the risk of cervical intraepithelial neoplasia 2/3 and cervical cancer: A nested case-control study in the Swiss HIV cohort study | Q40355308 | ||
| Use of the nonavalent HPV vaccine in individuals previously fully or partially vaccinated with bivalent or quadrivalent HPV vaccines | Q40831570 | ||
| Prevalence of cervical infection by human papillomavirus and cervical intraepithelial neoplasia in HIV-positive and negative women | Q41215315 | ||
| Human papillomavirus infection in human immunodeficiency virus-seropositive women | Q43869588 | ||
| Prevalence and genotype characterization of human papillomaviruses among HIV-seropositive in Ouagadougou, Burkina Faso. | Q43930567 | ||
| HPV detection and genotyping as an earlier approach in cervical cancer screening of the female genital tract. | Q44706226 | ||
| High prevalence of human papillomavirus infection in the female population of Guatemala | Q44778659 | ||
| Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women. | Q45477958 | ||
| Increased risk of cervical disease among human immunodeficiency virus-infected women with severe immunosuppression and high human papillomavirus load(1). | Q45740875 | ||
| Functional attributes of mucosal immunity in cervical intraepithelial neoplasia and effects of HIV infection | Q46215592 | ||
| Variations in the age-specific curves of human papillomavirus prevalence in women worldwide. | Q50627829 | ||
| Human papillomavirus types among women infected with HIV: a meta-analysis. | Q51776078 | ||
| Prevalence and multiplicity of HPV in HIV women in Minas Gerais, Brazil. | Q54351680 | ||
| Prevalence of human papillomavirus (HPV) type 16 variants and rare HPV types in the central Amazon region. | Q54386566 | ||
| [Human papillomavirus: prevalence and genotypes found among HIV-positive and negative women at a reference center in the far south of Brazil]. | Q54423509 | ||
| High grade cervical lesions are caused preferentially by non-European variants of HPVs 16 and 18. | Q54561703 | ||
| Population-Level Impact of the Bivalent, Quadrivalent, and Nonavalent Human Papillomavirus Vaccines: A Model–Based Analysis | Q57089346 | ||
| Overview of the European and North American studies on HPV testing in primary cervical cancer screening | Q57414808 | ||
| Human papillomavirus—the most significant risk determinant of cervical intraepithelial neoplasia | Q58176202 | ||
| The male role in cervical cancer | Q58296657 | ||
| Presence of multiple human papillomavirus types in cervical samples from HIV-infected women | Q58857234 | ||
| Epidemiology of HPV infection among Mexican women with normal cervical cytology | Q73421792 | ||
| Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica | Q81714676 | ||
| Human papillomavirus infection among sexually active young women in the United States: Implications for developing a vaccination strategy | Q83006286 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 36 | |
| P577 | publication date | 2018-02-17 | |
| P1433 | published in | Virology Journal | Q7934868 |
| P1476 | title | High risk human papillomavirus prevalence and genotype distribution among women infected with HIV in Manaus, Amazonas | |
| P478 | volume | 15 |
| Q64083502 | A cross-sectional analysis of factors associated with detection of oncogenic human papillomavirus in human immunodeficiency virus-infected and uninfected Kenyan women |
| Q59354969 | Cervico-vaginal self-collection in HIV-infected and uninfected women from Tapajós region, Amazon, Brazil: High acceptability, hrHPV diversity and risk factors |
Search more.